PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25790148-15 2015 CONCLUSION: The combination of milrinone, esmolol and vasopressin decreased cardiac injury compared with vasopressin alone. Milrinone 31-40 arginine vasopressin Homo sapiens 105-116 15632822-2 2005 This study compared the vasopressin-induced contraction and the effects of milrinone, nitroglycerin, and nitroprusside in vasopressin-induced contraction between the human radial artery and the internal thoracic artery to find effective antispastic methods for arterial grafts. Milrinone 75-84 arginine vasopressin Homo sapiens 122-133 16675238-4 2006 We hypothesized that vasopressin could recover hypotension induced by milrinone with less effect on pulmonary vascular resistance (PVR) compared to norepinephrine. Milrinone 70-79 arginine vasopressin Homo sapiens 21-32 16675238-12 2006 CONCLUSIONS: In the patients undergoing CABG surgery, both norepinephrine and low dose vasopressin were effective in restoring milrinone-induced decrease of SVR. Milrinone 127-136 arginine vasopressin Homo sapiens 87-98 16675238-13 2006 However, only low-dose vasopressin decreased the PVR/SVR ratio that was increased by milrinone. Milrinone 85-94 arginine vasopressin Homo sapiens 23-34 15617582-9 2005 After adjustment for vasopressin, milrinone was significantly more potent in increasing cardiac output (P <0.0001) and stroke volume (P=0.03), while decreasing vascular resistance (P <0.0001) and systolic blood pressure (P=0.008), than dobutamine. Milrinone 34-43 arginine vasopressin Homo sapiens 21-32 16939712-0 2006 Is vasopressin really superior to norepinephrine in reversing milrinone-induced vasodilation? Milrinone 62-71 arginine vasopressin Homo sapiens 3-14 15632822-6 2005 Pretreatment with milrinone and nitroprusside significantly inhibited vasopressin contraction in the internal thoracic artery but had little effect in the radial artery. Milrinone 18-27 arginine vasopressin Homo sapiens 70-81 12148128-5 2002 Previous case reports documented vasopressin as an effective alternative to catecholamines in the treatment of milrinone-induced hypotension. Milrinone 111-120 arginine vasopressin Homo sapiens 33-44 12148128-7 2002 Vasopressin may be the most effective vasopressor agent in the treatment of milrinone-induced hypotension. Milrinone 76-85 arginine vasopressin Homo sapiens 0-11 10728962-0 2000 Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Milrinone 32-41 arginine vasopressin Homo sapiens 0-11 10728962-2 2000 In patients with decompensated heart failure with hypotension after treatment with milrinone, low doses of vasopressin restored blood pressure without inhibiting the inotropic effect of milrinone. Milrinone 83-92 arginine vasopressin Homo sapiens 107-118 33858886-5 2021 As PAH was refractory to iNO and milrinone, vasopressin was added which resulted in rapid improvement in oxygenation and normalisation of pulmonary artery pressures. Milrinone 33-42 arginine vasopressin Homo sapiens 44-55 10667533-0 2000 Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Milrinone 68-77 arginine vasopressin Homo sapiens 0-11 10667533-9 2000 CONCLUSIONS: Vasopressin at very low doses appears to be an effective vasopressor for milrinone-induced hypotension. Milrinone 86-95 arginine vasopressin Homo sapiens 13-24